BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Tikvah Therapeutics 



Atlanta  Georgia    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Tikvah Therapeutics to Present At Lazard Capital Markets Healthcare Conference On November 27 11/16/2007 1:06:23 PM    More...
Tikvah Therapeutics Selected for 'Main-Stage' Presentation At the Ninth Annual Southeastern BIO Investor Forum 11/1/2007 9:28:22 AM    More...
Tikvah Therapeutics and Chakra Biotech Pte. Ltd. Establish Collaboration to Accelerate the Development of Novel Antipsychotic Compounds 9/5/2007 9:37:00 AM    More...
Tikvah Therapeutics Signs Agreement with Phase 2 Discovery, Inc. to Develop and Commercialize LY156735, a Second Generation Melatonin Agonist, for Circadian Rhythm and Sleep Disorders 8/29/2007 7:26:13 AM    More...
FDA Grants Tikvah Therapeutics Orphan Drug Status for Sodium Phenylbutyrate for the Treatment of Spinal Muscular Atrophy 8/20/2007 7:27:19 AM    More...
Tikvah Therapeutics Names Jack W. Callicutt Vice President and Chief Financial Officer 8/9/2007 9:40:18 AM    More...
Tikvah Therapeutics Licenses Unique Solution Formulations Useful in the Treatment of Neurodegenerative Diseases, Including Spinal Muscular Atrophy, From Navinta, LLC 8/7/2007 11:11:48 AM    More...
Tikvah Therapeutics Names Nathan Andrew Shapira, M.D., Ph.D. Executive Director of Clinical Research and Development and Deputy Chief Medical Officer 8/2/2007 9:37:45 AM    More...
Tikvah Therapeutics Licenses Academia Sinica Patent Estate Related to the Diagnosis, Method of Use, and Treatment of Neurodegenerative Diseases Including Spinal Muscular Atrophy 7/24/2007 8:45:56 AM    More...
Tikvah Therapeutics Enters an Exclusive Licensing Agreement With Apkarian Technologies Related to Agents for Treatment of Pain and Pain-Related Indications 7/16/2007 11:59:52 AM    More...
12

//-->